Amgen

IPO

A worldwide pioneer in biotechnology

Public · Thousand Oaks, United States · Founded 1980 · $19.0M raised

Employees
10001+
Founded
1980
Business Model
B2B
Website
amgen.com
Total Funding
$19.0M
Last Round
$19.0M Venture RoundApr 1980
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Amgen is a multinational biopharmaceutical company and pioneer of the biotechnology industry, founded in 1980 in Thousand Oaks, California. The company uses human genetic data and cutting-edge biology to discover and manufacture innovative medicines targeting serious illnesses including cancer, cardiovascular disease, osteoporosis, and inflammatory conditions. Amgen's portfolio spans both novel biologics and biosimilars, reaching millions of patients across more than 100 countries. With over 40 years of experience in recombinant DNA technology, Amgen remains one of the world's largest independent biotechnology companies.

Summary

Amgen is a Biotech company based in Thousand Oaks, United States, founded in 1980. It has raised $19.0M in total across 1 round, most recently a $19.0M Venture Round in Apr 1980. Investors include William K. Bowes.

Tech & App Stack

22 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 1983
$40.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Amgen on Indexed.vc
<a href="https://indexed.vc/companies/amgen"><img src="https://indexed.vc/api/badge/company/amgen" alt="Amgen on Indexed.vc" width="260" height="76" /></a>